Head-to-head · computed 2026-08-11
Hims & Hers vs Sprout Health
Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping. Sprout Health: Sprout Health sells flat-rate compounded GLP-1s with no membership: $249/month semaglutide (commonly $199 first month; $615 three-month supply, about $205/month) and $299/month tirzepatide (commonly $249 first month), with a published price-lock so the rate holds as the dose climbs — and, unusually for this market, two named partner pharmacies.
Tirzepatide
| Hims & Hers | Sprout Health | |
|---|---|---|
| All-in maintenance | $548/mo | $299/mo |
| Best plan rate | $548/mo | $299/mo |
| 12-month total | $6,576 | $3,588 |
| Status | Reported · 2026-08-11 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Sprout Health's $299 a month undercuts Hims & Hers's $548 by $249 a month at the 10 mg/wk maintenance basis — $2,988 across a year. Sprout Health's figure is reported (captured 2026-08-11) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's tirzepatide ladder runs $548 a month billed monthly. Sprout Health's runs $299 a month billed monthly. On the twelve-month basis Sprout Health's $3,588 beats Hims & Hers's $6,576 by $2,988 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Sprout Health promotional terms: First month commonly $249.
Semaglutide
| Hims & Hers | Sprout Health | |
|---|---|---|
| All-in maintenance | $453/mo | $249/mo |
| Best plan rate | $453/mo | $205/mo |
| 12-month total | $5,436 | $2,988 |
| Status | Reported · 2026-08-11 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Sprout Health's $249 a month undercuts Hims & Hers's $453 by $204 a month at the 2.4 mg/wk maintenance basis — $2,448 across a year. Sprout Health's figure is reported (captured 2026-08-11) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's semaglutide ladder runs $453 a month billed monthly. Sprout Health's runs $249 a month billed monthly, and $205 a month on a three-month plan. On the twelve-month basis Sprout Health's $2,988 beats Hims & Hers's $5,436 by $2,448 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Sprout Health promotional terms: First month commonly $199; three-month supply $615 (~$205/mo).
Where the structures genuinely differ
Sprout Health carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, Sprout Health is dose-flat — the price survives titration — while Hims & Hers's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
Sprout Health
- MembershipNone
- Dose policyDose-flat with a published price-lock guarantee: the enrolled rate does not increase as the dose escalates
- CommitmentMonth-to-month; 3-month semaglutide supply available
- CancellationPer provider terms
- PharmacyFoothills Pharmacy and Promise Pharmacy (named partners)
What our desk is watching on each
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Sprout Health: Resolution on record: our July 16 homepage read ('starting-at entry-dose prices; funnel personalizes') is superseded — five independent 2026 sources converge on flat $249/$299 pricing with an explicit dose price-lock, identifying the homepage 'starting at' as first-month promo framing rather than dose tiering. LegitScript-certified; MD Integrations clinician network; Sprout Health Partners LLC, Encinitas, CA. Cautions that survive the upgrade: a consistent slow-customer-service complaint pattern across review sources, an NAD+ add-on on the menu (see the verification masterclass's add-on cautions), oral compounded tirzepatide tablets offered (less outcome data than injectables), and no labs or telehealth visit required before treatment — fast is not the same as thorough.
Questions people ask
Is Hims & Hers or Sprout Health cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Hims & Hers vs Sprout Health miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Hims & Hers and Sprout Health cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $6,576 at Hims & Hers and $3,588 at Sprout Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Does a promotion affect this comparison?
Yes — at least one program on this page (Sprout Health) is running promotional pricing with its standard rate card stored alongside it. The verdict uses the price a buyer pays today, labeled as promotional; the analysis block prints the reversion figure, because a comparison won on a sale that ends is a comparison that expires.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Hims & Hers · Sprout Health. Official sites: Hims & Hers ↗ · Sprout Health ↗. Nothing here is medical advice.